ISSN 15265161
16 papers in the library · 58 citations · publishing 2024-2026
American Journal of Bioethics 2026 Katherine Cheung, Brian D. Earp, Kyle Patch et al.
We are grateful to those who commented on our Target Article on ethical exceptionalism around psychedelics (see Box 1 for a summary of our main points) and to Cohen and Marks (2025) for their compl...
American Journal of Bioethics July 30, 2025 Caleigh Propes, Katherine Cheung 1 citation
Informed consent aims, amongst other goals, to provide robust information to prospective participants on the risks and benefits that they may incur during a study. However, participant misconceptio...
American Journal of Bioethics July 7, 2025 Veronika Gold 1 citation
I am requesting a correction to the article “Focused Bodywork as Facilitated Communication: Cautionary Perspectives on Touch in Psychedelic Therapy” by Neşe Devenot (2025). The article contains fac...
American Journal of Bioethics July 1, 2025 Joel Janhonen, Juuso Kähönen, Joona Räsänen 5 citations
In his work on informed consent, Daniel Villiger (2025a) credibly argues that ignorance concerning the outcomes of transformative treatments need not undermine patient autonomy, while prohibitions ...
American Journal of Bioethics 2025 Daniel Villiger 7 citations
The presence of unusual features in psychedelic treatments has led to the argument that these treatments are exceptional within medicine and should therefore also be treated as exceptional when ana...
American Journal of Bioethics 2025 Neşe Devenot 3 citations
On August 9, 2024, the U.S. Food and Drug Administration (FDA) declined to approve Lykos Therapeutics’ application for MDMA-assisted therapy (MDMA-AT), in alignment with the recommendation of its i...
American Journal of Bioethics 2025 Jarrel de Matas, A. L. Mcguire, Hasan Yasin 3 citations
In their contribution to the rapidly developing field of research on psychedelic medicine, Glenn Cohen and Mason Marks shed light on a frequently overlooked but critical aspect of ethical considera...
American Journal of Bioethics 2025 Zachary J Verne, Natalie Gukasyan, Jeffrey S Zabinski 2 citations
In “Distinctive but not Exceptional: The Risks of Psychedelic Ethical Exceptionalism,” Cheung et al. (2025) elaborate the ways that psychedelics share individual ethical considerations with those o...
American Journal of Bioethics 2025 T. Findley 2 citations
of Votes 2020). Along with acknowledging that providing treatment for addiction is more beneficial than criminal charges, Measure 110 directed the state, through OHA, to create a statewide network of addiction recovery centers, providing ample grant funding to existing providers to do so
American Journal of Bioethics 2025 Susan Lee, Mikaela Kim, Grayson R Jackson et al. 1 citation
Drawing on comparisons to genetic exceptionalism, Cheung et al. (2025) reject psychedelic exceptionalism—that psychedelics raise unique concerns regarding increased vulnerability and diminished aut...
American Journal of Bioethics 2025 Naomi Scheinerman, Claire Erickson 1 citation
Exceptionalism in bioethics generally refers to the idea that a particular medical development or intervention warrants special consideration, either ethically or legally, given its unique features...
American Journal of Bioethics 2025 K. Blevins 1 citation
Psychedelic ethics is at a crossroads. Confronted with the undeniable harm wrought by a widespread embrace of exceptionalism, many are approaching psychedelics not only in the context of urgent men...
American Journal of Bioethics 2025 Shen Pan, David Wendler 1 citation
Increased interest in psychedelic treatments has raised concern regarding consent and whether it can be sufficiently informed. One source of concern is that psychedelic substances are prone to elic...
American Journal of Bioethics 2025 Juuso Kähönen, Joel Janhonen, Joona Räsänen 1 citation
The use of psychedelics has recently gained increased interest among bioethicists, as the articles published in this journal attest. Some of the recent scholarship suggests that psychedelic experie...
American Journal of Bioethics 2025 Katrina Debonis, Walter Dunn, Thomas B. Strouse
The resurgence of psychedelic research has brought with it unique ethical considerations, including the role of personal psychedelic experience among facilitators. Some have argued that personal ps...
American Journal of Bioethics May 2, 2024 Edward Jacobs, Brian D. Earp, Paul S. Appelbaum et al. 29 citations
The first Hopkins-Oxford Psychedelic Ethics (HOPE) workshop convened to discuss ethical matters relating to psychedelics in August 2023 at the University of Oxford.The organizers (BDE, DBY, EJ) aim...